Colchicine Market is expected to reach 1270 million US$ by 2025, QY Research

Colchicine is an alkaloid extracted from the bulb of colchicum. This medicine is used to treat acute attacks of gouty arthritis and prevent acute exacerbation of recurrent gouty arthritis.

Colchicine is a highly effective drug for the treatment of acute gout, but 50% to 80% of patients taking colchicine have had gastrointestinal side effects before the onset of gout, which has affected the growth of the colchicine market.

Colchicine has been FDA approved for use in combination with probenicid for gout since 1982. As part of a program to promote safety studies for grandfathered meds, in 2009 the FDA approved its use for acute gout flares, gout prophylaxis, and Familial Mediterranean Fever. It is also used off-label for pseudogout, Behcet’s disease, pericarditis, and primary biliary cirrhosis.

In 2018, the market size of Colchicine is 920 million US$ and it will reach 1270 million US in 2025, growing at a CAGR of 4.0% from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US in 2025, with a CAGR of xx% during forecast period.

In this report, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Colchicine.

This study researches the market size of Colchicine in United States, European Union and China, presents the Colchicine sales, revenue, market share and growth rate by companies, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/838905/global-united-states-european-union-and-china-colchicine-market

For top companies in United States, European Union and China, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

In United States, European Union and China market, the following companies are covered:

Takeda Pharmaceuticals

Hikma

Cipla

Wockhardt

West-Ward

Excellium Pharmaceutical

Rhea Pharmaceutical

Medinova

Odan Laboratories

Prasco

Kunming Pharmaceutical

Yunnan Plant Medicine

Xishuangbanna Pharmaceutical

Guangdong Pedi

Yunnan Shan State

Tonghua Limin

Beijing Jialin Pharmaceutical

Market Segment by Product Type

Tablet

Oral Solution

Market Segment by Application

Acute Gout

Chronic Gout

Other Conditions

Key Regions split in this report:

United States

China

European Union

Rest of World (Japan, Korea, India and Southeast Asia)

Buy Full market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/b84536489bed1b86e78a219d0809a25d,0,1,Global%20United%20States%252C%20European%20Union%20and%20China%20Colchicine%20Market%20Research%20Report%202018-2025

About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA - 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – sales@qyresearch.com
Web – www.qyresearch.com
Expert News: https://www.qyresearch.com/expert/list

This release was published on openPR.